Regulation of CYP3A genes in the human respiratory tract

Chemico-Biological Interactions

Volumn 151, Issue 2, 2005, Pages 53-62

  Raunio, Hannu ^a   Hakkola, Jukka ^b   Pelkonen, Olavi ^b  

^a UNIVERSITY OF EASTERN FINLAND   (Finland)

^b UNIVERSITY OF OULU   (Finland)

Author keywords

Cytochrome P450; Gene regulation; Human lung; Nuclear receptor; Xenobiotic metabolism

Indexed keywords

BILE ACID; CARCINOGEN; CELL NUCLEUS RECEPTOR; CONSTITUTIVE ANDROSTANE RECEPTOR; CYTOCHROME P450 3A; CYTOCHROME P450 3A4; CYTOCHROME P450 3A43; CYTOCHROME P450 3A5; CYTOCHROME P450 3A7; GLUCOCORTICOID; GLUCOCORTICOID RECEPTOR; HEPATIC NUCLEAR FACTOR 4 ALPHA; LIGAND; PREGNANE X RECEPTOR; STEROID; TRANSCRIPTION FACTOR; UNCLASSIFIED DRUG;

ADRENAL GLAND; BILE ACID METABOLISM; BRONCHUS; CARCINOMA CELL; CELL TYPE; CIGARETTE SMOKING; CYTOCHROME P450 3A4 GENE; CYTOCHROME P450 3A43 GENE; CYTOCHROME P450 3A5 GENE; CYTOCHROME P450 3A7 GENE; DOWN REGULATION; DRUG METABOLISM; ENZYME ACTIVITY; GENE; GENE CONTROL; GENE EXPRESSION; GENE EXPRESSION REGULATION; GENE FREQUENCY; GENETIC ANALYSIS; GENETIC REGULATION; GENETIC TRANSFECTION; HUMAN; INTESTINE WALL; KIDNEY; LIVER; LUNG ADENOCARCINOMA; LUNG ALVEOLUS CELL; LUNG ALVEOLUS EPITHELIUM; LUNG ALVEOLUS MACROPHAGE; LUNG DISEASE; METABOLISM; POLLUTANT; PROSTATE; PROTEIN CONTENT; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; REGULATORY MECHANISM; RESPIRATORY SYSTEM; SHORT SURVEY; STEROID METABOLISM; TISSUE; TISSUE SPECIFICITY; TRANSCRIPTION REGULATION; UPREGULATION;

EID: 13444293231     PISSN: 00092797     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cbi.2003.12.007     Document Type: Review

References (55)

1. F.P. Guengerich Cytochrome P-450 3A4: regulation and role in drug metabolism Annu. Rev. Pharmacol. Toxicol. 39 1999 1 17
2. O. Burk, L. Wojnowski, Cytochrome P450 3A and their regulation, Naunyn Schmiedebergs Arch. Pharmacol, Oct 21, 2003 (e-pub ahead of print).
3. J. Hakkola, E. Tanaka, and O. Pelkonen Developmental expression of cytochrome P450 enzymes in human liver Pharmacol. Toxicol. 82 1998 209 217
4. R.N. Hines, and D.G. McCarver The ontogeny of human drug-metabolising enzymes: phase I oxidative enzymes J. Pharmacol. Exp. Ther. 300 2002 355 360
5. T.L. Domanski, C. Finta, J.R. Halpert, and P.G. Zaphiropoulos cDNA cloning and initial characterization of CYP3 A43, a novel human cytochrome P450 Mol. Pharmacol. 59 2001 386 392
6. K. Gellner, R. Eiselt, E. Hustert, H. Arnold, I. Koch, M. Haberl, C.J. Deglmann, O. Burk, D. Buntefuss, S. Escher, C. Bishop, H.G. Koebe, U. Brinkmann, H.P. Klenk, K. Kleine, U.A. Meyer, and L. Wojnowski Genomic organization of the human CYP3A locus: identification of a new, inducible CYP3A gene Pharmacogenetics 11 2001 111 121
7. A. Westlind, S. Malmebo, I. Johansson, C. Otter, T.B. Andersson, M. Ingelman-Sundberg, and M. Oscarson Cloning and tissue distribution of a novel human cytochrome p450 of the CYP3A subfamily, CYP3A43 Biochem. Biophys. Res. Commun. 281 2001 1349 1355
8. E. Hustert, M. Haberl, O. Burk, R. Wolbold, Y.Q. He, K. Klein, A.C. Nuessler, P. Neuhaus, J. Klattig, R. Eiselt, I. Koch, A. Zibat, J. Brockmoller, J.R. Halpert, U.M. Zanger, and L. Wojnowski The genetic determinants of the CYP3A5 polymorphism Pharmacogenetics 11 2001 773 779
9. P. Kuehl, J. Zhang, Y. Lin, J. Lamba, M. Assem, J. Schuetz, P.B. Watkins, A. Daly, S.A. Wrighton, S.D. Hall, P. Maurel, M. Relling, C. Brimer, K. Yasuda, R. Venkataramanan, S. Strom, K. Thummel, M.S. Boguski, and E. Schuetz Sequence diversity in CYP3A promoters and characterization of the genetic basis of polymorphic CYP3A5 expression Nat. Genet. 27 2001 383 391
10. J.K. Lamba, Y.S. Lin, E.G. Schuetz, and K.E. Thummel Genetic contribution to variable human CYP3A-mediated metabolism Adv. Drug Deliv. Rev. 54 2002 1271 1294
11. I. Koch, R. Weil, R. Wolbold, J. Brockmoller, E. Hustert, O. Burk, A. Nuessler, P. Neuhaus, M. Eichelbaum, U. Zanger, and L. Wojnowski Interindividual variability and tissue-specificity in the expression of cytochrome P450 3A mRNA Drug Metab. Dispos. 30 2002 1108 1114
12. A. Westlind-Johnsson, S. Malmebo, A. Johansson, C. Otter, T.B. Andersson, I. Johansson, R.J. Edwards, A.R. Boobis, and M. Ingelman-Sundberg Comparative analysis of CYP3A expression in human liver suggests only a minor role for CYP3A5 in drug metabolism Drug Metab. Dispos. 31 2003 755 761
13. B. Goodwin, M.R. Redinbo, and S.A. Kliewer Regulation of CYP3A gene transcription by the pregnane X receptor Annu. Rev. Pharmacol. Toxicol. 42 2002 1 23
14. P.-Y. Chen, and E.T. Morgan Hepatic cytochrome P450 regulation in disease states Curr. Drug Metab. 2 2001 155 183
15. F.J. Gonzalez, and Y.H. Lee Constitutive expression of hepatic cytochrome P450 genes FASEB J. 10 1996 1112 1117
16. T.E. Akiyama, and F.J. Gonzalez Regulation of P450 genes by liver-enriched transcription factors and nuclear receptors Biochim. Biophys. Acta 1619 2003 223 234
17. R. Jover, R. Bort, M.J. Gomez-Lechon, and J.V. Castell Down-regulation of human CYP3A4 by the inflammatory signal interleukin-6: molecular mechanism and transcription factors involved FASEB J. 16 2002 1799 1801
18. M.J. Gomez-Lechon, M.T. Donato, J.V. Castell, and R. Jover Human hepatocytes as a tool for studying toxicity and drug metabolism Curr. Drug Metab. 4 2003 292 312
19. C. Rodriguez-Antona, R. Bort, R. Jover, N. Tindberg, M. Ingelman-Sundberg, M.J. Gomez-Lechon, and J.V. Castell Transcriptional regulation of human CYP3A4 basal expression by CCAAT enhancer-binding protein α and hepatocyte nuclear factor-3γ Mol. Pharmacol. 63 2003 1180 1189
20. P. Honkakoski Nuclear receptors CAR and PXR in metabolism and elimination of drugs Curr. Pharmacogenomics 1 2003 75 85
21. G.G. Gibson, N.J. Plant, K.E. Swales, A. Ayrton, and W. El-Sankary Receptor-dependent transcriptional activation of cytochrome P4503A genes: induction mechanisms, species differences and interindividual variation in man Xenobiotica 32 2002 165 206
22. Y.S. Lin, A.L. Dowling, S.D. Quigley, F.M. Farin, J. Zhang, J. Lamba, E.G. Schuetz, and K.E. Thummel Co-regulation of CYP3A4 and CYP3A5 and contribution to hepatic and intestinal midazolam metabolism Mol. Pharmacol. 62 2002 162 172
23. T. Aoyama, S. Yamano, D.J. Waxman, D.P. Lapenson, U.A. Meyer, V. Fischer, R. Tyndale, T. Inaba, W. Kalow, H.V. Gelboin, and F.J. Gonzalez Cytochrome P-450 hPCN3, a novel cytochrome P-450 IIIA gene product that is differentially expressed in adult human liver. cDNA and deduced amino acid sequence and distinct specificities of cDNA-expressed hPCN1 and hPCN3 for the metabolism of steroid hormones and cyclosporine J. Biol. Chem. 264 1989 10388 10395
24. C. Finta, and P.G. Zaphiropoulos The human cytochrome P450 3A locus. Gene evolution by capture of downstream exons Gene 260 2000 13 23
25. J. Hukkanen, T. Väisänen, A. Lassila, R. Piipari, S. Anttila, O. Pelkonen, H. Raunio, and J. Hakkola Regulation of CYP3A5 by glucocorticoids and cigarette smoke in human lung-derived cells J. Pharmacol. Exp. Ther. 304 2003 745 752
26. R.G. Tirona, W. Lee, B.F. Leake, L.B. Lan, C.B. Cline, V. Lamba, F. Parviz, S.A. Duncan, Y. Inoue, F.J. Gonzalez, E.G. Schuetz, and R.B. Kim The orphan nuclear receptor HNF4α determines PXR- and CAR-mediated xenobiotic induction of CYP3A4 Nat. Med. 9 2003 220 224
27. J. Hukkanen, O. Pelkonen, J. Hakkola, and H. Raunio Expression and regulation of xenobiotic-metabolizing cytochrome P450 (CYP) enzymes in human lung Crit. Rev. Toxicol. 32 2002 391 411
28. X. Ding, and L.S. Kaminsky Human extrahepatic cytochromes P450: function in xenobiotic metabolism and tissue-selective chemical toxicity in the respiratory and gastrointestinal tracts Annu. Rev. Pharmacol. Toxicol. 43 2003 149 173
29. H. Autrup Carcinogen metabolism in cultured human tissues and cells Carcinogenesis 11 1990 707 712
30. H. Foth Role of the lung in accumulation and metabolism of xenobiotic compounds - implications for chemically induced toxicity Crit. Rev. Toxicol. 26 1995 165 205
31. K.T. Kivisto, P. Fritz, A. Linder, G. Friedel, P. Beaune, and H.K. Kroemer Immunohistochemical localization of cytochrome P450 3A in human pulmonary carcinomas and normal bronchial tissue Histochem. Cell Biol. 103 1995 25 29
32. K.T. Kivisto, E.U. Griese, P. Fritz, A. Linder, J. Hakkola, H. Raunio, P. Beaune, and H.K. Kroemer Expression of cytochrome P 450 3A enzymes in human lung: a combined RT-PCR and immunohistochemical analysis of normal tissue and lung tumours Naunyn Schmiedebergs Arch. Pharmacol. 353 1996 207 212
33. S. Anttila, J. Hukkanen, J. Hakkola, T. Stjernvall, P. Beaune, R.J. Edwards, A.R. Boobis, O. Pelkonen, and H. Raunio Expression and localization of CYP3A4 and CYP3A5 in human lung Am. J. Respir. Cell Mol. Biol. 16 1997 242 249
34. K. Mace, E.D. Bowman, P. Vautravers, P.G. Shields, C.C. Harris, and A.M. Pfeifer Characterisation of xenobiotic-metabolising enzyme expression in human bronchial mucosa and peripheral lung tissues Eur. J. Cancer 34 1998 914 920
35. J. Hukkanen, A. Lassila, K. Päivärinta, S. Valanne, S. Sarpo, J. Hakkola, O. Pelkonen, and H. Raunio Induction and regulation of xenobiotic-metabolizing cytochrome P450s in the human A549 lung adenocarcinoma cell line Am. J. Respir. Cell Mol. Biol. 22 2000 360 366
36. J.D. Schuetz, E.G. Schuetz, J.V. Thottassery, P.S. Guzelian, S. Strom, and D. Sun Identification of a novel dexamethasone responsive enhancer in the human CYP3A5 gene and its activation in human and rat liver cells Mol. Pharmacol. 49 1996 63 72
37. J.M. Pascussi, S. Gerbal-Chaloin, L. Drocourt, P. Maurel, and M.J. Vilarem The expression of CYP2B6, CYP2C9 and CYP3A4 genes: a tangle of networks of nuclear and steroid receptors Biochim. Biophys. Acta 1619 2003 243 253
38. M. Haag, A. Fautrel, A. Guillouzo, N. Frossard, and F. Pons Expression of cytochromes P450 3A in mouse lung: effects of dexamethasone and pregnenolone 16alpha-carbonitrile Arch. Toxicol. 77 2003 145 149
39. T.J. Cole, J.A. Blendy, A.P. Monaghan, K. Krieglstein, W. Schmid, A. Aguzzi, G. Fantuzzi, E. Hummler, K. Unsicker, and G. Schutz Targeted disruption of the glucocorticoid receptor gene blocks adrenergic chromaffin cell development and severely retards lung maturation Genes Dev. 9 1995 1608 1621
40. F.P. Guengerich, and T. Shimada Activation of procarcinogens by human cytochrome P450 enzymes Mutat. Res. 400 1998 201 213
41. J.C. Willey, E. Coy, C. Brolly, M.J. Utell, M.W. Frampton, J. Hammersley, W.G. Thilly, D. Olson, and K. Cairns Xenobiotic metabolism enzyme gene expression in human bronchial epithelial and alveolar macrophage cells Am. J. Respir. Cell Mol. Biol. 14 1996 262 271
42. J. Hukkanen, J. Hakkola, S. Anttila, R. Piipari, A. Karjalainen, O. Pelkonen, and H. Raunio Detection of mRNA encoding xenobiotic-metabolizing cytochrome P450s in human bronchoalveolar macrophages and peripheral blood lymphocytes Mol. Carcinog. 20 1997 224 230
43. R. Piipari, K. Savela, T. Nurminen, J. Hukkanen, H. Raunio, J. Hakkola, T. Mantyla, P. Beaune, R.J. Edwards, A.R. Boobis, and S. Anttila Expression of CYP1A1, CYP1B1 and CYP3A, and polycyclic aromatic hydrocarbon-DNA adduct formation in bronchoalveolar macrophages of smokers and non-smokers Int. J. Cancer 86 2000 610 616
44. R. Piipari, T. Nurminen, K. Savela, A. Hirvonen, T. Mantyla, and S. Anttila Glutathione S-transferases and aromatic DNA adducts in smokers' bronchoalveolar macrophages Lung Cancer 39 2003 265 272
45. H. Zhang, E. LeCulyse, L. Liu, M. Hu, L. Matoney, W. Zhu, and B. Yan Rat pregnane X receptor: molecular cloning, tissue distribution, and xenobiotic regulation Arch. Biochem. Biophys. 368 1999 14 22
46. U. Savas, M.R. Wester, K.J. Griffin, and E.F. Johnson Rabbit pregnane X receptor is activated by rifampicin Drug Metab. Dispos. 28 2000 529 537
47. D. Warburton, M. Schwarz, D. Tefft, G. Flores-Delgado, K.D. Anderson, and W.V. Cardoso The molecular basis of lung morphogenesis Mech. Dev. 92 2000 55 81
48. T. Drewes, S. Senkel, B. Holewa, and G.U. Ryffel Human hepatocyte nuclear factor 4 isoforms are encoded by distinct and differentially expressed genes Mol. Cell. Biol. 16 1996 925 931
49. T.N. Cassel, and M. Nord C/EBP transcription factors in the lung epithelium Am. J. Physiol. Lung Cell. Mol. Physiol. 285 2003 L773 L781
50. T. Skarin, R. Becher, A. Bucht, K. Duvefelt, S. Bohm, T. Ranneberg-Nilsen, E.M. Lilleaas, P.E. Schwarze, and R. Toftgard Cis-acting sequences from the rat cytochrome P450 2B1 gene confer pulmonary and phenobarbital-inducible expression in transgenic mice Am. J. Respir. Cell Mol. Biol. 21 1999 177 184
51. T.N. Cassel, J.A. Gustafsson, and M. Nord CYP2B1 is regulated by C/EBP alpha and C/EBP delta in lung epithelial cells Mol. Cell. Biol. Res. Commun. 3 2000 42 47
52. B.A. Carr, J. Wan, R.N. Hines, and G.S. Yost Characterization of the human lung CYP2F1 gene and identification of a novel lung-specific binding motif J. Biol. Chem. 278 2003 15473 15483
53. F. Raffalli-Mathieu, T. Glisovic, Y. Ben-David, and M.A. Lang Heterogeneous nuclear ribonucleoprotein A1 and regulation of the xenobiotic-inducible gene Cyp2a5 Mol. Pharmacol. 61 2002 795 799
54. A. Kamat, M.M. Hinshelwood, B.A. Murry, and C.R. Mendelson Mechanisms in tissue-specific regulation of estrogen biosynthesis in humans Trends Endocrinol. Metab. 13 2002 122 128
55. Y. Yamakoshi, T. Kishimoto, K. Sugimura, and H. Kawashima Human prostate CYP3A5: identification of a unique 5′-untranslated sequence and characterization of purified recombinant protein Biochem. Biophys. Res. Commun. 260 1999 676 681